Dexamethasone Improves Cardiovascular Outcomes in Critically Ill COVID-19, a Real World Scenario Multicenter Analysis

BACKGROUND: Severe COVID-19 pneumonia requiring intensive care treatment remains a clinical challenge to date. Dexamethasone was reported as a promising treatment option, leading to a reduction of mortality rates in severe COVID-19 disease. However, the effect of dexamethasone treatment on cardiac i...

Descripción completa

Detalles Bibliográficos
Autores principales: Jirak, Peter, van Almsick, Vincent, Dimitroulis, Dimitrios, Mirna, Moritz, Seelmaier, Clemens, Shomanova, Zornitsa, Wernly, Bernhard, Semo, Dilvin, Dankl, Daniel, Mahringer, Magdalena, Lichtenauer, Michael, Hoppe, Uta C., Reinecke, Holger, Pistulli, Rudin, Larbig, Robert, Motloch, Lukas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847392/
https://www.ncbi.nlm.nih.gov/pubmed/35186995
http://dx.doi.org/10.3389/fmed.2022.808221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847392/
https://www.ncbi.nlm.nih.gov/pubmed/35186995
http://dx.doi.org/10.3389/fmed.2022.808221

Ejemplares similares